JMCP Award for Excellence
The Journal of Managed Care + Specialty Pharmacy (JMCP) Award for Excellence was established in 2002 to recognize an article that represents the best scholarly work in managed care pharmacy.
Articles considered for nomination must have been published in JMCP in the calendar year prior to the award presentation.
Each member of the JMCP Editorial Advisory Board may nominate one (1) or two (2) articles for consideration with justification for each nomination. One article is selected. Honorable Mentions may be given.
A 7-member panel of judges is convened each year that is comprised of three (3) members of the JMCP Editorial Advisory Board and four (4) JMCP Peer Reviewers who have contributed high-quality reviews. The nominated articles are evaluated by the Judges Panel according to the following measures:
- Impact on the profession or knowledge/thought leadership.
- Relevance to managed care pharmacy today.
- Scientific merit and sound methodology.
- Clarity of purpose and hypothesis.
- Writing quality and readability.
NATURE OF AWARD:
The JMCP Award for Excellence is presented at the spring meeting. The recipient(s) receive a plaque and complimentary registration and travel expenses for one author to receive the award.
For articles published in:
Racial/Ethnic and Gender Disparities in the Use of Erythropoiesis-Stimulating Agents and Blood Transfusions: Cancer Management Under Medicare’s Reimbursement Policy. Authors: Minghui Li, PhD; Richard Schulz, PhD; Marie Chisholm-Burns, PharmD; Junling Wang, PhD; and Z. Kevin Lu, PhD
Development of Quality Indicators to Assess Oral Anticoagulant Management in Community Pharmacies for Patients with Atrial Fibrillation. Authors: Chartrand M, Guenette L, Brouilette D, et al.
Using Performance-Based Risk-Sharing Arrangements to Address Uncertainty in Indication-Based Pricing. Authors: Kai Yeung, PharmD, PhD, Meng Li, ScM , and Josh J. Carlson, PhD, MPH
Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia. Authors: Joanna P. MacEwan, PhD, Felicia M. Forma, BSc, Jason Shafrin, PhD, Ainslie Hatch, PhD, Darius N. Lakdawalla, PhD, Jean-Pierre Lindenmayer, MD
Improving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion Test Assessment Tool (CAT). Authors: William J. Canestaro, Louis P. Garrison, David L. Veenstra, Daryl E. Pritchard, Robert Dubois.
Is There an Association Between the High-Risk Medication Star Ratings and Member Experience CMS Star Ratings Measure? Authors: Sara Carruth Erickson, R. Scott Leslie, Bimal V. Patel.
The Effect of Hepatitis C Treatment Response on Medical Costs: A Longitudinal Analysis in an Integrated Care Setting. Authors: M. Michel Manos, Jeanne Darbinian, Jaime Rubin, G. Thomas Ray, Valentina Shvachko, Baris Denis, Futon Velez, Charles Qusenberry.
Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction. Authors: Stephen J. Kogut, Brian J. Quilliam, Scott Johnson and Tara Higgens.
Discontinuation Rates and Health Care Costs in Adult Patients Starting Generic Versus Brand SSRI or SNRI Antidepressants in Commercial Health Plans. Authors: Anna Vlahiotis, Scott Devine, Jeff Eichholz, Adam Kautzner.
Addition of Generic Medication Vouchers to a Pharmacist Academic Detailing Program: Effects on the Generic Dispensing Ratio in a Physician-Hospital Organization. Authors: Vinay Bhargava, Mark E. Greg, Mark C. Shields.
Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy. Authors: Patrick P. Gleason, Catherine I. Starner, Brent Gundeson, and Jeremy Schafer. One Honorable Mention was also given.
Rosiglitazone and Piolitazone Utilization from January 2007 through May 2009 Associated with Five Risk-Warning Events. Authors: Catherine I. Starner, Jeremy A. Schafer, and Patrick P. Gleason and Alan Heaton. One Honorable Mention was also given.
Comparison of Mail-Order with Community Pharmacy in Plan Sponsor Cost and Member Cost in Two Large Pharmacy Benefit Plans. Authors: Michael Johnsrud, Kenneth A. Lawson, and Marvin D. Shepherd. Two Honorable Mentions were also given.
Analysis of the Effectiveness and Cost Benefit of Leukotriene Modifiers in Adults with Asthma in the Ohio Medicaid Population. Authors: Pamela Heaton, Jeff J. Guo, Richard W. Hornung, Joseph A. Johnston, Raymon Jang, Charles J. Moomaw, and Robert Cluxton all, except Johnston, are with University of Cincinnati. Johnston was with the University of Cincinnati Medical Center. Two Honorable Mentions were also given.
Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration. Authors: Son Hee Hong, Marvin D. Shepherd, David Scoones, and Thomas T.H. Wan. Two Honorable Mentions were also given.
Randomized Controlled Trial of a Dose Consolidation Program. Authors: Thomas Delate, Kathleen A. Fairman, Shell Carey, and Brenda Motherall.
Do Decision-Analytic Models Identify Cost-Effective Treatments? A Retrospective Look at Helicobacter Pylori Eradication. Authors: Kathleen A. Fariman and Brenda Motheral. Two Honorable Mentions were also given.
Effects of a Tablet-Splitting Program in Patients Taking HMG-CoA Reductase Inhibitors: Analysis of Clinical Effects, Patient Satisfaction, Compliance and Cost Avoidance. Authors: Michael Gee, Noelle K. Hasson, Terri Jahn, and Russell Ryono. Two Honorable Mentions were also given.